| |
Academic Staff
Adjunct Staff
Research Staff
|
|
|
|
Academic Qualifications
|
| B.Sc. Pharm (Hons)
| 1982 |
University of Houston |
| Ph.D. |
1987 |
University of California,
San Francisco |
|
Victor C. K. Yu spent one year in Neurex Corporation as a
staff scientist before joining the Howard Hughes Medical Institute
at the University of California, San Diego, as a Leukemia
Society of America fellow. He joined the IMCB in 1993 and
is now an Associate Professor.
|
| Research
Interests |
- Mechanism Of Apoptosis In Mammalian Cells
Programmed Cell Death: Suicide Machine for the
Ultimate Sacrifice
When a cell in our body becomes severely damaged to the
point that it could be harmful to the neighboring cells,
the cell commits suicide. Recent evidence suggests that
improper functioning of the cell suicide program is a
major contributing factor to many human diseases

Schematic illustration of representative
signaling pathways of apoptosis in mammalian cells
Apoptosis, or programmed cell death, is the process by
which a cell actively commits suicide using tightly controlled
mechanisms. It occurs through the activation of a cell-intrinsic
suicide program. The basic core machinery necessary to carry
out apoptosis appears to be present in essentially all cells
at all times. However, activation of the suicide program
is highly regulated and under the tight control of a network
of interrelated signals to ensure the proper functioning
of this important physiological process. It is believed
that the malfunction of this signaling system is one of
the important causes of some human diseases, including cancer
(insufficient cell death) and Alzheimers disease (excessive
cell death). Dr. Yus lab is investigating the function
and regulation of the apoptotic signaling processes in mammalian
cells. They studied the signaling and regulatory mechanisms
that control the apoptotic function of the tumor suppresser
protein, p53, in human neuroblastoma (one of the most common
forms of childhood cancer) and discovered that the translocation
defect of p53 in these cells could be restored by a small
molecular weight compound known as H-7 (1-(5-isoquinolinesulfonyl)-2-methylpiperazine).
Because H-7 appears to kill neuroblastoma cells through
the p53-dependent pathway, the H7-neuroblastoma cell model
system thus becomes a powerful tool to permit the identification
and understanding of the molecular steps involved in p53-mediated
apoptosis. To facilitate the identification of the additional
signaling components that are involved in apoptosis, they
have also employed a protein-protein interaction cloning
strategy to identify genes that encode proteins that can
specifically associate with some of the key molecules in
the death signaling pathway. Emphasis has been placed on
identifying genes that play important roles in mediating
cell death in the brain. Currently, several novel genes,
including a gene that is expressed exclusively in the brain,
have been identified and their functions in apoptosis signaling
are being actively studied in Dr. Yus laboratory.
Novel therapeutic approaches can be devised by identifying
important molecules that participate in the signaling events
in apoptosis and by gaining an understanding of how these
molecules are being regulated.

|
|
|